Inhibition of Glycosphingolipid Synthesis Ameliorates Atherosclerosis and Arterial Stiffness in Apolipoprotein E −/− Mice and Rabbits Fed a High-Fat and -Cholesterol Diet
Author(s) -
Subroto Chatterjee,
Djahida Bedja,
Sumita Mishra,
Christine Amuzie,
Alberto Avolio,
David A. Kass,
Dan E. Berkowitz,
Mark Renehan
Publication year - 2014
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.113.007559
Subject(s) - endocrinology , medicine , lactosylceramide , glycosphingolipid , lipoprotein , cholesterol , apolipoprotein b , apolipoprotein e , biology , biochemistry , enzyme , disease
Glycosphingolipids, integral components of the cell membrane, have been shown to serve as messengers, transducing growth factor-initiated phenotypes. Here, we have examined whether inhibition of glycosphingolipid synthesis could ameliorate atherosclerosis and arterial stiffness in transgenic mice and rabbits.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom